Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel

Pharmaceutical Research

Volumn 31, Issue 4, 2014, Pages 1032-1045

  Song, Shuangshuang ^a   Chen, Fen ^a   Qi, Huan ^a   Li, Fei ^a   Xin, Tiegang ^a   Xu, Jingwen ^a   Ye, Tiantian ^a   Sheng, Naicheng ^b   Yang, Xinggang ^a   Pan, Weisan ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF METAL RESEARCH   (China)

Author keywords

CD44; docetaxel; hyaluronic acid; multifunctional targeting; pH sensitivity

Indexed keywords

CHOLESTEROL HYDROGEN SUCCINATE; DOCETAXEL; HERMES ANTIGEN; HYALURONIC ACID; NANOCARRIER; ANTINEOPLASTIC AGENT; DRUG CARRIER; NANOPARTICLE; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RELEASE; ENDOCYTOSIS; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MOUSE; NANOENCAPSULATION; NONHUMAN; NUDE MOUSE; PARTICLE SIZE; PH; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR MODEL; TUMOR REGRESSION; TUMOR VOLUME; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; MCF 7 CELL LINE; PHYSIOLOGY; PROCEDURES; RANDOMIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL SURVIVAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYALURONIC ACID; HYDROGEN-ION CONCENTRATION; MCF-7 CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; RANDOM ALLOCATION; TAXOIDS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84897094416     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-013-1225-y     Document Type: Article

References (40)

1. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev. 2001;46:149-68.
2. Allenand TM, Cullis PR. Drug delivery systems: entering the mainstream. Science. 2004;303:1818-22.
3. Iyer AK, Khaled G, Fang J, Maeda H. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006;11:812-8.
4. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271-84.
5. Xiang G, Wu J, Lu Y, Liu Z, Lee RJ. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm. 2008;356:29-36.
6. Hatakeyama H, Akita H, Maruyama K, Suhara T, Harashima H. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int J Pharm. 2004;281:25-33.
7. Chen Y, Youn P, Furgeson DY. Thermo-targeted drug delivery of geldanamycin to hyperthermic tumor margins with diblock elastin-based biopolymers. J Control Release. 2011;155:175-83.
8. Xu H, Deng Y, Chen D, Hong W, Lu Y, Dong X. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives. J Control Release. 2008;130:238-45.
9. Shen M, Huang Y, Han L, Qin J, Fang X, Wang J, et al. Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. J Control Release. 2012;161:884-92.
10. Choi KY, Chung H, Min KH, Yoon HY, Kim K, Park JH, et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials. 2010;31:106-14.
11. Robert L, Robert AM, Renard G. Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging. Pathol Biol. 2010;58:187-98.
12. Schanté CE, Zuber G, Herlin C, Vandamme TF. Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications. Carbohydr Polym. 2011;85:469-89.
13. Yin D-S, Z-q G, W-y Y, C-x L, Y-j Y. Inhibition of tumor metastasis in vivo by combination of paclitaxel and hyaluronic acid. Cancer Lett. 2006;243:71-9.
14. Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, et al. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Int J Pharm. 2011;421:160-9.
15. Orian-Rousseau V. CD44, a therapeutic target for metastasising tumours. Eur J Cancer. 2010;46:1271-7.
16. Journo-Gershfeld G, Kapp D, Shamay Y, Kopeček J, David A. Hyaluronan oligomers-HPMA copolymer conjugates for targeting paclitaxel to CD44-overexpressing ovarian carcinoma. Pharm Res. 2012;29:1121-33.
17. Xin D, Wang Y, Xiang J. The use of amino acid linkers in the conjugation of paclitaxel with hyaluronic acid as drug delivery system: synthesis, self-assembled property, drug release, and in vitro efficiency. Pharm Res. 2010;27:380-9.
18. Upadhyay KK, Bhatt AN, Mishra AK, Dwarakanath BS, Jain S, Schatz C, et al. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes. Biomaterials. 2010;31:2882-92.
19. Raviña M, Cubillo E, Olmeda D, Novoa-Carballal R, Fernandez-Megia E, Riguera R, et al. Hyaluronic acid/chitosan-g-Poly(ethylene glycol) nanoparticles for gene therapy: an application for pDNA and siRNA delivery. Pharm Res. 2010;27:2544-55.
20. Upadhyay KK, Bhatt AN, Mishra AK, Dwarakanath BS, Jain S, Schatz C, et al. The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes. Biomaterials. 2010;31:2882-92.
21. Carafa M, Di Marzio L, Marianecci C, Cinque B, Lucania G, Kajiwara K, et al. Designing novel pH-sensitive non-phospholipid vesicle: characterization and cell interaction. Eur J Pharm Sci. 2006;28:385-93.
22. Hafezand IM, Cullis PR. Cholesteryl hemisuccinate exhibits pH sensitive polymorphic phase behavior. Biochim Biophys Acta (BBA) Biomembr. 2000;1463:107-14.
23. Simões S, Moreira JN, Fonseca C, Düzgüneş N, Pedroso de Lima MC. On the formulation of pH-sensitive liposomes with long circulation times. Adv Drug Deliv Rev. 2004;56:947-65.
24. Naik S, Patel D, Chuttani K, Mishra AK, Misra A. In vitro mechanistic study of cell death and in vivo performance evaluation of RGD grafted PEGylated docetaxel liposomes in breast cancer. Nanomedicine Nanotechnol Biol Med. 2012;8:951-62.
25. Morikawa Y, Koike H, Sekine Y, Matsui H, Shibata Y, Ito K, et al. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation. Biochem Biophys Res Commun. 2012;419:584-9.
26. Kintzel PE, Michaud LB, Lange MK. Docetaxel-associated epiphora. Pharmacother J Hum Pharmacol Drug Ther. 2006;26:853-67.
27. Danquah MK, Zhang XA, Mahato RI. Extravasation of polymeric nanomedicines across tumor vasculature. Adv Drug Deliv Rev. 2011;63:623-39.
28. Baker J, Ajani J, Scotté F, Winther D, Martin M, Aapro MS, et al. Docetaxel-related side effects and their management. Eur J Oncol Nurs. 2009;13:49-59.
29. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M, Kataoka K. Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem. 2004;16:122-30.
30. Muthu MS, Rawat MK, Mishra A, Singh S. PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine Nanotechnol Biol Med. 2009;5:323-33.
31. Li N, Zhuang C, Wang M, Sun X, Nie S, Pan W. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm. 2009;379:131-8.
32. Carafa M, Di Marzio L, Marianecci C, Cinque B, Lucania G, Kajiwara K, et al. Designing novel pH-sensitive non-phospholipid vesicle: characterization and cell interaction. Eur J Pharm Sci. 2006;28:385-93.
33. Lavasanifar A, Samuel J, Kwon GS. Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery. Adv Drug Deliv Rev. 2002;54:169-90.
34. Liu Q, Wu J, Tan T, Zhang L, Chen D, Tian W. Preparation, properties and cytotoxicity evaluation of a biodegradable polyester elastomer composite. Polym Degrad Stab. 2009;94:1427-35.
35. Ungaro F, Conte C, Ostacolo L, Maglio G, Barbieri A, Arra C, et al. Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. Nanomedicine Nanotechnol Biol Med. 2012;8:637-46.
36. Peerand D, Margalit R. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer. 2004;108:780-9.
37. Rivkin I, Cohen K, Koffler J, Melikhov D, Peer D, Margalit R. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials. 2010;31:7106-14.
38. Plattand VM, Szoka FC. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor. Mol Pharm. 2008;5:474-86.
39. Zhou B, Weigel JA, Fauss L, Weigel PH. Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem. 2000;275:37733-41.
40. Cho H-J, Yoon I-S, Yoon HY, Koo H, Jin Y-J, Ko S-H, et al. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin. Biomaterials. 2012;33:1190-200.